中文产业新闻精选评分68Chinese source
CSL 15.55亿美元引进Alentis靶向Claudin-1单抗lixudebart
CSL 15.55亿美元押注Claudin-1：肾病赛道的重磅新玩家
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
CSL 15.55亿美元押注Claudin-1：肾病赛道的重磅新玩家
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.